Skip to content

Clinical trials

Completed Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Status: Completed Clear all

307 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200110
200211
200319
200414
200518
200616
200718
200816
200919
201012
201114
20129
20138
20148
20155
201610
20179
20181
20198
20205
20215
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed307

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)37
Fred Hutchinson Cancer Center31
Dana-Farber Cancer Institute15
Mayo Clinic13
Memorial Sloan Kettering Cancer Center11
Roswell Park Cancer Institute8
Case Comprehensive Cancer Center7
SWOG Cancer Research Network7
Jonsson Comprehensive Cancer Center6
Alliance for Clinical Trials in Oncology5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia307
Leukemia, Lymphocytic, Chronic, B-Cell220
Lymphoma, Follicular215
Lymphoma, B-Cell, Marginal Zone214
Lymphoma, Mantle-Cell199
Lymphoma, Non-Hodgkin188
Lymphoma, Large B-Cell, Diffuse174
Burkitt Lymphoma161
Precursor Cell Lymphoblastic Leukemia-Lymphoma158
Lymphoma, Large-Cell, Immunoblastic145

Trials

Showing 1 to 25 of 307. Each trial links to its page on Pharma Observatory.

207 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.